Wegovy and Ozempic Lawsuit Information

Ozempic and Wegovy are part of a class of drugs known as GLP-1 (glucagon-like peptide 1) agonists. They are widely used for the treatment of type 2 diabetes and, more recently, as a tool for weight loss.

Wegovy and Ozempic, both known by the generic name semaglutide, along with another semaglutide medication called Rybelsus from Novo Nordisk, stimulate insulin production in the pancreas. This process lowers blood sugar levels and slows down digestion, which can help decrease appetite and make individuals feel fuller for a longer time.

However, semaglutide comes with a number of risks that plaintiffs allege drug manufacturers should have better communicated to patients, including gastrointestinal distress, gallbladder disorders, and other potentially serious medical complications.

Under current legislation, drug manufacturers are legally required to meet a few obligations when communicating facts about their products to patients and doctors:

• Duty to warn: Pharmaceutical companies must warn of all potential side effects of a drug they are aware of, no matter how rare.
• Duty to label: Medication labels require a clear, concise, and easy-to-understand description that covers all relevant warnings.
• Duty to update: If the drug manufacturer learns of new risks to their product, they must put in a meaningful effort to update providers.
• Duty to report: Drug manufacturers must publicly report adverse effects of their products to providers and consumers.

At this time, more than five dozen diabetes drug class action lawsuit claims have been filed against Novo Nordisk for failure to properly warn of the side effects of Ozempic and Wegovy – an allegation that, if true, shows negligent actions on the part of the company.

If you experienced injury from taking semaglutide and do not feel like you were sufficiently warned of side effects, a Wegovy or Ozempic lawsuit could help you protect your rights and win just compensation.

According to more than one class action lawsuit, diabetes medication manufacturer Novo Nordisk failed to meet the duty to warn standard required by federal legislation.

Potential side effects of semaglutide drugs Wegovy and Ozempic include:

• Gastroparesis (stomach paralysis)
• Chronic nausea and vomiting
• Pancreatitis
• Pancreatic cancer
• Vision loss
• Gallbladder disease
• Kidney damage
• Bowel or intestinal obstructions
• Malnutrition disorders
• Esophageal injury

These side effects can be debilitating. They can also be incredibly costly, resulting in steep medical bills, lost wages, and chronic health complications.
Our team at Gordon & Partners has more than 30 years of dedicated experience representing victims against well-funded drug companies. A qualified Wegovy/Ozempic lawyer from our team can help you file a separate Ozempic or Wegovy lawsuit or potentially join a diabetes drug class action lawsuit. We offer zero-obligation, free consultations.

Your first step, if you believe you have a valid claim against Novo Nordisk, is to speak to a specialized Wegovy or Ozempic lawyer.
A pharmaceutical litigation attorney will help you through the process of filing a diabetes drug class action lawsuit or personal suit, with services that may include:

• Evaluating the strength of your claim based on medical records, expert testimony, and other forms of evidence
• Completing all associated paperwork associated with filing a drug manufacturer lawsuit
• Negotiating a fair settlement on your behalf or advocating for your rights in front of a judge or jury

If you or a loved one have experienced major medical complications such as stomach paralysis or gallbladder disease from any of the aforementioned GLP-1 drugs, you deserve to have your rights protected. Call (855) 722-2552 today for a free consultation and overview of your legal options.